Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Roger

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Pharmaceutical Statistics|January 4, 2012
Statistical approaches for conducting network meta-analysis in drug developmentByron Jones, James Roger, Peter W Lane, et al.
Clinical Immunology (Orlando, Fla.)|January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletionPaul M Barr, Chungwen Wei, James Roger, et al.
Pharmaceutical Statistics|March 22, 2016
Estimands: discussion points from the PSI estimands and sensitivity expert groupAlan Phillips, Juan Abellan-Andres, Andersen Soren, et al.
Pharmaceutical Statistics|October 22, 2009
Missing data: discussion points from the PSI missing data expert groupTomasz Burzykowski, James Carpenter, Corneel Coens, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pharmaceutical Statistics|January 4, 2012
Statistical approaches for conducting network meta-analysis in drug developmentByron Jones, James Roger, Peter W Lane, et al.
Clinical Immunology (Orlando, Fla.)|January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletionPaul M Barr, Chungwen Wei, James Roger, et al.
Pharmaceutical Statistics|March 22, 2016
Estimands: discussion points from the PSI estimands and sensitivity expert groupAlan Phillips, Juan Abellan-Andres, Andersen Soren, et al.
Pharmaceutical Statistics|October 22, 2009
Missing data: discussion points from the PSI missing data expert groupTomasz Burzykowski, James Carpenter, Corneel Coens, et al.
Pageof 2